Plant-based virus-like particles, recombinant, adjuvanted COVID-19 vaccine

DB16757

biotech approved

Deskripsi

The Covifenz COVID-19 vaccine (plant-based virus-like particles (VLP), recombinant, adjuvanted) is a plant-based vaccine developed in partnership by Medicago and GlaxoSmithKline which is approved in Canada for the prevention of COVID-19.L40694 It is composed of VLPs expressing SARS-CoV-2 spike protein trimers (stabilized in a pre-fusion conformation) and is mixed with the AS03 adjuvant system prior to administration.L40694

While the concept of plant-based VLPs as vaccines is not new,A245824 it is a novel approach to COVID-19 vaccination, with previously approved COVID-19 vaccines mostly comprising viral vector (e.g. the AstraZeneca COVID-19 vaccine) and nucleic acid vaccines (e.g. the Moderna COVID-19 vaccine).A245819 Plant-based VLPs offer a number of advantages as compared to other vaccine platforms, including speed and ease of manufacturing and increased immunogenicity.A245824 In addition, VLPs contain no viral material and are therefore inherently non-infectious, making them potentially safer alternatives to traditional vaccines.A245824

Struktur Molekul 2D

Struktur tidak tersedia

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

0 Data
Tidak ada data.

Referensi & Sumber

Artikel (PubMed)
  • PMID: 35206580
    Simoes RSQ, Rodriguez-Lazaro D: Classical and Next-Generation Vaccine Platforms to SARS-CoV-2: Biotechnological Strategies and Genomic Variants. Int J Environ Res Public Health. 2022 Feb 18;19(4). pii: ijerph19042392. doi: 10.3390/ijerph19042392.
  • PMID: 22995837
    Chen Q, Lai H: Plant-derived virus-like particles as vaccines. Hum Vaccin Immunother. 2013 Jan;9(1):26-49. doi: 10.4161/hv.22218. Epub 2012 Sep 20.
  • PMID: 22380826
    Garcon N, Vaughn DW, Didierlaurent AM: Development and evaluation of AS03, an Adjuvant System containing alpha-tocopherol and squalene in an oil-in-water emulsion. Expert Rev Vaccines. 2012 Mar;11(3):349-66. doi: 10.1586/erv.11.192.

Contoh Produk & Brand

Produk: 0 • International brands: 1
International Brands
  • Covifenz — Medicago, Inc.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul